Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 299
Filter
1.
J Electrocardiol ; 86: 153777, 2024.
Article in English | MEDLINE | ID: mdl-39178814

ABSTRACT

Data capture systems that acquire continuous hospital-based electrocardiographic (ECG) and physiologic (vital signs) data can foster robust research (i.e., large sample sizes from consecutive patients). However, the application of these systems and the data generated are complex and requires careful human oversight to ensure that accurate and high quality data are procured. This technical article will describe two different data capture systems created by our research group designed to examine false alarms associated with alarm fatigue in nurses. The following aspects regarding these data capture systems will be discussed: (1) history of development; (2) summary of advantages, challenges, and important considerations; (3) their use in research; (4) their use in clinical care; and (5) future developments.


Subject(s)
Electrocardiography , Humans , Clinical Alarms , Electrocardiography/methods , Monitoring, Physiologic/methods
2.
Chemosphere ; 362: 142731, 2024 Aug.
Article in English | MEDLINE | ID: mdl-38950744

ABSTRACT

Biosynthesized nanocomposites, particularly those incorporating carbon-based materials, exhibit exceptional tunability and multifunctionality, surpassing the capabilities of conventional materials in these aspects. Developing practical solutions is critical to address environmental toxins from pharmaceuticals, heavy metals, pesticides, and dyes. Biomass waste is a readily available carbon source, which emerges as a promising material for producing biochar due to its inherent advantages: abundance, low cost, and environmentally friendly nature. This distribution mainly uses carbon-based materials (CBMs) and biomass waste in wastewater treatment. This review paper investigates several CBM types, including carbon aerogels, nanotubes, graphene, and activated carbon. The development of bio-derived carbon-based nanomaterials are discussed, along with the properties and composition of carbon materials derived from biomass waste and various cycles, such as photodegradation, adsorption, and high-level oxidation processes for natural remediation. In conclusion, this review examines the challenges associated with biochar utilization, including cost, recovery, and practical implementation.


Subject(s)
Carbon , Charcoal , Environmental Restoration and Remediation , Wastewater , Wastewater/chemistry , Environmental Restoration and Remediation/methods , Carbon/chemistry , Charcoal/chemistry , Waste Disposal, Fluid/methods , Water Pollutants, Chemical/chemistry , Water Pollutants, Chemical/analysis , Adsorption , Biomass , Graphite/chemistry , Nanocomposites/chemistry , Water Purification/methods
3.
Vaccine ; 42(24): 126109, 2024 Oct 24.
Article in English | MEDLINE | ID: mdl-38981740

ABSTRACT

The Bacille Calmette-Guerin (BCG) vaccine is a well-established inducer of innate immune memory (also termed trained immunity), causing increased cytokine production upon heterologous secondary stimulation. Innate immune responses are known to be influenced by season, but whether seasons impact induction of trained immunity is not known. To explore the influence of season on innate immune memory induced by the BCG vaccine, we vaccinated healthy volunteers with BCG either during winter or spring. Three months later, we measured the ex vivo cytokine responses against heterologous stimuli, analyzed gene expressions and epigenetic signatures of the immune cells, and compared these with the baseline before vaccination. BCG vaccination during winter induced a stronger increase in the production of pro-inflammatory cytokines by peripheral blood mononuclear cells (PBMCs) upon stimulation with different bacterial and fungal stimuli, compared to BCG vaccination in spring. In contrast, winter BCG vaccination resulted in lower IFNγ release in PBMCs compared to spring BCG vaccination. Furthermore, NK cells of the winter-vaccinated people had a greater pro-inflammatory cytokine and IFNγ production capacity upon heterologous stimulation. BCG had only minor effects on the transcriptome of monocytes 3 months later. In contrast, we identified season-dependent epigenetic changes in monocytes and NK cells induced by vaccination, partly explaining the higher immune cell reactivity in the winter BCG vaccination group. These results suggest that BCG vaccination during winter is more prone to induce a robust trained immunity response by activating and reprogramming the immune cells, especially NK cells. (Dutch clinical trial registry no. NL58219.091.16).


Subject(s)
BCG Vaccine , Cytokines , Immunity, Innate , Immunologic Memory , Leukocytes, Mononuclear , Seasons , Humans , BCG Vaccine/immunology , BCG Vaccine/administration & dosage , Adult , Male , Cytokines/immunology , Cytokines/metabolism , Leukocytes, Mononuclear/immunology , Female , Young Adult , Killer Cells, Natural/immunology , Vaccination , Healthy Volunteers , Interferon-gamma/immunology , Interferon-gamma/metabolism , Trained Immunity
4.
Int J Toxicol ; 43(4_suppl): 42-77, 2024 Oct.
Article in English | MEDLINE | ID: mdl-39049435

ABSTRACT

The Expert Panel for Cosmetic Ingredient Safety (Panel) assessed the safety of three methylxanthines, Caffeine, Theobromine, and Theophylline, as used in cosmetics. All of these ingredients are reported to function as skin-conditioning agents in cosmetic products. The Panel reviewed the data relevant to the safety of these ingredients and concluded that Caffeine, Theobromine, and Theophylline are safe in cosmetics in the present practices of use and concentration described in this safety assessment.


Subject(s)
Consumer Product Safety , Cosmetics , Humans , Cosmetics/toxicity , Cosmetics/chemistry , Animals , Caffeine/toxicity , Caffeine/pharmacokinetics , Theobromine/toxicity , Theophylline/toxicity , Theophylline/pharmacokinetics , Risk Assessment , Toxicity Tests , Xanthines/toxicity
5.
Vaccines (Basel) ; 12(6)2024 Jun 20.
Article in English | MEDLINE | ID: mdl-38932420

ABSTRACT

SARS-CoV-2 infections elicit antibodies against the viral spike (S) and nucleocapsid (N) proteins; COVID-19 vaccines against the S-protein only. The BCG-Corona trial, initiated in March 2020 in SARS-CoV-2-naïve Dutch healthcare workers, captured several epidemic peaks and the introduction of COVID-19 vaccines during the one-year follow-up. We assessed determinants of systemic anti-S1 and anti-N immunoglobulin type G (IgG) responses using trial data. Participants were randomised to BCG or placebo vaccination, reported daily symptoms, SARS-CoV-2 test results, and COVID-19 vaccinations, and donated blood for SARS-CoV-2 serology at two time points. In the 970 participants, anti-S1 geometric mean antibody concentrations (GMCs) were much higher than anti-N GMCs. Anti-S1 GMCs significantly increased with increasing number of immune events (SARS-CoV-2 infection or COVID-19 vaccination): 104.7 international units (IU)/mL, 955.0 IU/mL, and 2290.9 IU/mL for one, two, and three immune events, respectively (p < 0.001). In adjusted multivariable linear regression models, anti-S1 and anti-N log10 concentrations were significantly associated with infection severity, and anti-S1 log10 concentration with COVID-19 vaccine type/dose. In univariable models, anti-N log10 concentration was also significantly associated with acute infection duration, and severity and duration of individual symptoms. Antibody concentrations were not associated with long COVID or long-term loss of smell/taste.

6.
J Cardiothorac Vasc Anesth ; 38(8): 1769-1776, 2024 Aug.
Article in English | MEDLINE | ID: mdl-38862283

ABSTRACT

The authors thank the editors for this opportunity to review the recent literature on vascular surgery and anesthesia and provide this clinical update. The last in a series of updates on this topic was published in 2019.1 This review explores evolving discussions and current trends related to vascular surgery and anesthesia that have been published since then. The focus is on the major points discussed in the recent literature in the following areas: carotid artery surgery, infrarenal aortic surgery, peripheral vascular surgery, and the preoperative evaluation of vascular surgical patients.


Subject(s)
Anesthesia , Vascular Surgical Procedures , Humans , Vascular Surgical Procedures/methods , Anesthesia/methods
7.
Crit Care Explor ; 6(5): e1082, 2024 May.
Article in English | MEDLINE | ID: mdl-38694845

ABSTRACT

OBJECTIVES: To evaluate the relationship between early IV fluid volume and hospital outcomes, including death in-hospital or discharge to hospice, in septic patients with and without heart failure (HF). DESIGN: A retrospective cohort study using logistic regression with restricted cubic splines to assess for nonlinear relationships between fluid volume and outcomes, stratified by HF status and adjusted for propensity to receive a given fluid volume in the first 6 hours. An ICU subgroup analysis was performed. Secondary outcomes of vasopressor use, mechanical ventilation, and length of stay in survivors were assessed. SETTING: An urban university-based hospital. PATIENTS: A total of 9613 adult patients were admitted from the emergency department from 2012 to 2021 that met electronic health record-based Sepsis-3 criteria. Preexisting HF diagnosis was identified by the International Classification of Diseases codes. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: There were 1449 admissions from patients with HF. The relationship between fluid volume and death or discharge to hospice was nonlinear in patients without HF, and approximately linear in patients with HF. Receiving 0-15 mL/kg in the first 6 hours was associated with lower likelihood of death or discharge to hospice compared with 30-45 mL/kg (odds ratio = 0.61; 95% CI, 0.41-0.90; p = 0.01) in HF patients, but no significant difference for non-HF patients. A similar pattern was identified in ICU admissions and some secondary outcomes. Volumes larger than 15-30 mL/kg for non-HF patients and 30-45 mL/kg for ICU-admitted non-HF patients were not associated with improved outcomes. CONCLUSIONS: Early fluid resuscitation showed distinct patterns of potential harm and benefit between patients with and without HF who met Sepsis-3 criteria. Restricted cubic splines analysis highlighted the importance of considering nonlinear fluid outcomes relationships and identified potential points of diminishing returns (15-30 mL/kg across all patients without HF and 30-45 mL/kg when admitted to the ICU). Receiving less than 15 mL/kg was associated with better outcomes in HF patients, suggesting small volumes may be appropriate in select patients. Future studies may benefit from investigating nonlinear fluid-outcome associations and a focus on other conditions like HF.


Subject(s)
Fluid Therapy , Heart Failure , Sepsis , Humans , Retrospective Studies , Male , Female , Heart Failure/therapy , Heart Failure/mortality , Aged , Middle Aged , Fluid Therapy/methods , Sepsis/mortality , Sepsis/therapy , Cohort Studies , Hospital Mortality , Intensive Care Units , Length of Stay
8.
Clin Ter ; 175(3): 184-192, 2024.
Article in English | MEDLINE | ID: mdl-38767077

ABSTRACT

Background: Variations in cystic artery anatomy are not unusual in occurrence, hence considerably crucial during hepatobiliary surgical planning and execution. This systematic review and meta-analysis of the anatomical variations of cystic artery (CA) was undertaken to emphasize their significance in surgical practice. Methods: The PICO model was adopted, both MeSH term and free keywords were utilized for the search strategy. The risk of bias in each study was calculated by the anatomy quality assurance (AQUA) tool. Result: The search strategy identified 8204 records, extracted 5529 studies, and evaluated 117 abstracts. Out of these 117 studies, 53 met the eligibility criteria. The CA was absent in 2% of instances (95% CI: 0.01-0.04), indicating that 98% of cases had the CA. In 10071 participants from 29 investigations, double cystic arteries were found in 13% (95% CI: 11-16%), with significant heterogeneity (I2 = 91%). In 46 studies with a total of 9928 participants, 89% of the individuals had CA originating from RHA (95% CI: 85%-92%) with significant heterogeneity (I2=94.3%) and a predictive range of 43%-99%. Conclusion: The cystic artery is primarily derived from the right hepatic artery, followed by aberrant, proper, and left hepatic arteries. It is located anterior to common hepatic ducts and cystic ducts. The mean length and diameter of CA were 20.77 mm and 1.91 mm Short cystic arteries are common (20%) Congenital anomalies like absent and double cystic arteries have low prevalence but must be conside-red during surgery.


Subject(s)
Hepatic Artery , Humans , Hepatic Artery/anatomy & histology , Hepatic Artery/abnormalities , Anatomic Variation
9.
Allergy Asthma Proc ; 45(3): 186-194, 2024 May 01.
Article in English | MEDLINE | ID: mdl-38755777

ABSTRACT

Background: Concern of metal sensitization in pre- and postsurgical evaluation is growing, with the recent guidelines remaining the criterion standard for consideration of patch testing. Information remains scarce on surgical screening in the groups of patients who reported a history of metal sensitivity versus those with no reported history. Objective: The objective of this study was to assess the utility of patch testing in surgical candidates based on reported metal allergy history. The secondary objective was to evaluate the utility and outcomes in postsurgical patch testing. Methods: Nine hundred and thirty-one patient charts of patients with the diagnosis of "contact dermatitis" who underwent an evaluation at a single allergy clinic site between January 2013 and December 2022 were identified and reviewed as part of a retrospective chart review study. Patients were included in subgroups based on the time of patch testing and history of reported metal allergy. Results: In all, 67 patients underwent patch testing, 10 (14.9%) of whom were surgical candidates without a history of metal sensitivity, 31 (46.2%) of whom were surgical candidates with a history of metal sensitivity, and 26 (38.8%) of whom were postsurgical patients. Twenty-nine (43.3%) of patients had positive patch testing results, with only one (10%) in the presurgical group, 17 (54.8%) in the presurgical with a history of metal sensitivity, and 11 (42.3%) in the postsurgical group. Zero patients in our cohort without metal sensitivity who were undergoing the Nuss procedure had positive reactions on patch testing, whereas two of four (50%) with reported metal sensitivity who were undergoing the Nuss procedure had positive relevant metal reactions. Conclusion: Ambiguity in the utility of patch testing for surgical decision making remains, despite common utilization. Recent guidelines along with coordination of care among the surgeon, allergist, and patient remains the criterion standard of care.


Subject(s)
Metals , Patch Tests , Prostheses and Implants , Humans , Retrospective Studies , Metals/adverse effects , Male , Female , Middle Aged , Prostheses and Implants/adverse effects , Adult , Dermatitis, Allergic Contact/diagnosis , Dermatitis, Allergic Contact/etiology , Aged , Allergens/immunology
10.
J Am Coll Emerg Physicians Open ; 5(2): e13149, 2024 Apr.
Article in English | MEDLINE | ID: mdl-38596320

ABSTRACT

Objective: Recent clinical guidelines for sepsis management emphasize immediate antibiotic initiation for suspected septic shock. Though hypotension is a high-risk marker of sepsis severity, prior studies have not considered the precise timing of hypotension in relation to antibiotic initiation and how clinical characteristics and outcomes may differ. Our objective was to evaluate antibiotic initiation in relation to hypotension to characterize differences in sepsis presentation and outcomes in patients with suspected septic shock. Methods: Adults presenting to the emergency department (ED) June 2012-December 2018 diagnosed with sepsis (Sepsis-III electronic health record [EHR] criteria) and hypotension (non-resolving for ≥30 min, systolic blood pressure <90 mmHg) within 24 h. We categorized patients who received antibiotics before hypotension ("early"), 0-60 min after ("immediate"), and >60 min after ("late") treatment. Results: Among 2219 patients, 55% received early treatment, 13% immediate, and 32% late. The late subgroup often presented to the ED with hypotension (median 0 min) but received antibiotics a median of 191 min post-ED presentation. Clinical characteristics notable for this subgroup included higher prevalence of heart failure and liver disease (p < 0.05) and later onset of systemic inflammatory response syndrome (SIRS) criteria compared to early/immediate treatment subgroups (median 87 vs. 35 vs. 20 min, p < 0.0001). After adjustment, there was no difference in clinical outcomes among treatment subgroups. Conclusions: There was significant heterogeneity in presentation and timing of antibiotic initiation for suspected septic shock. Patients with later treatment commonly had hypotension on presentation, had more hypotension-associated comorbidities, and developed overt markers of infection (eg, SIRS) later. While these factors likely contribute to delays in clinician recognition of suspected septic shock, it may not impact sepsis outcomes.

11.
Ann Plast Surg ; 92(4S Suppl 2): S251-S254, 2024 Apr 01.
Article in English | MEDLINE | ID: mdl-38556683

ABSTRACT

INTRODUCTION: Malnutrition is associated with increased mortality in patients with head and neck (H&N) cancer. Because albumin levels are used as a surrogate for nutritional status, the purpose of this study is to assess whether malnutrition is associated with adverse postoperative outcomes in H&N free flap reconstruction. MATERIALS AND METHODS: The 2006-2018 National Surgical Quality Improvement Program Database was queried for patients undergoing flap procedures of the H&N based on Current Procedure Terminology codes. Patients were included if they were operated on by an otolaryngologist or when the primary surgical site was H&N. Nutritional status was categorized as malnourished (preoperative albumin level <3.5 g/dL) or normal (preoperative albumin level ≥3.5 g/dL). Major complications included pulmonary complications, cardiac complications, deep vein thrombosis/pulmonary embolism, and sepsis/septic shock. Minor complications included surgical infection, urinary tract infection, bleeding, and dehiscence. Data were analyzed via univariate chi-square and multivariate regression analyses. RESULTS: Of the patients, 2532 (83.3%) had normal albumin and 506 (16.7%) had hypoalbuminemia. Patients with hypoalbuminemia were more likely to have smoking history (P = 0.008), pulmonary comorbidity (P < 0.001), renal comorbidity (P = 0.018), disseminated cancer (P < 0.001), steroid use (P < 0.001), recent weight loss (P < 0.001), bleeding disorder (P = 0.023), and preoperative transfusion (P < 0.001). After adjustment for preoperative variance, malnourished patients were more likely to experience death (P < 0.001), return to operating room (P < 0.001), free flap failure (P = 0.008), pulmonary complication (P < 0.001), deep vein thrombosis/pulmonary embolism (P = 0.019), wound disruption (P = 0.042), intraoperative transfusion (P < 0.001), minor complication (P < 0.001), major complication (P < 0.001), and extended length of stay (P < 0.001). Of the patients with normal albumin, 2.1% experienced flap failure compared with 6.3% of patients with hypoalbuminemia. It should be noted that malnourished patients were 3.370 times more likely to experience flap failure (95% confidence interval, 1.383-8.212; P = 0.008) and 3.975 times more likely to experience death (95% confidence interval, 1.700-9.626; P = 0.001) than those with normal albumin. CONCLUSION: Malnutrition is associated with death, flap failure, minor complications, and other major complications following H&N free flap surgery, even after controlling for preoperative variance. Optimizing preoperative nutrition status before free flap procedures may ameliorate morbidity and mortality in H&N patients.


Subject(s)
Free Tissue Flaps , Head and Neck Neoplasms , Hypoalbuminemia , Malnutrition , Pulmonary Embolism , Venous Thrombosis , Humans , Hypoalbuminemia/complications , Retrospective Studies , Malnutrition/complications , Malnutrition/epidemiology , Head and Neck Neoplasms/complications , Head and Neck Neoplasms/surgery , Postoperative Complications/epidemiology , Postoperative Complications/etiology , Venous Thrombosis/complications , Albumins , Risk Factors
12.
Immunol Lett ; 267: 106851, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38479480

ABSTRACT

Bacillus Calmette-Guérin (BCG) vaccination induces memory characteristics in innate immune cells and their progenitors, a process called trained immunity mediated by epigenetic and metabolic reprogramming. Cholesterol synthesis plays an amplifying role in trained immunity through mevalonate release. Nitrogen-containing bisphosphonates (N-BPs), such as alendronate, can inhibit cholesterol synthesis. We explored their effects on trained immunity induced by BCG in a placebo-controlled clinical study (NL74082.091.20) in young, healthy individuals. Participants receiving single-dose oral alendronate on the day of BCG vaccination had more neutrophils and plasma cells one month after treatment. Alendronate led to reduced proinflammatory cytokine production by PBMCs stimulated with heterologous bacterial and viral stimuli one month later. Furthermore, the addition of alendronate transcriptionally suppressed multiple immune response pathways in PBMCs upon stimulation. Our findings indicate that N-BPs modulate the long-lasting effects of BCG vaccination on the cytokine production capacity of innate immune cells.


Subject(s)
Alendronate , BCG Vaccine , Cytokines , Leukocytes, Mononuclear , Vaccination , Humans , BCG Vaccine/immunology , BCG Vaccine/administration & dosage , Cytokines/metabolism , Alendronate/pharmacology , Male , Adult , Female , Young Adult , Leukocytes, Mononuclear/immunology , Leukocytes, Mononuclear/metabolism , Leukocytes, Mononuclear/drug effects , Immunity, Innate/drug effects , Healthy Volunteers , Immunologic Memory/drug effects
13.
Int J Toxicol ; 43(3_suppl): 5S-63S, 2024 Aug.
Article in English | MEDLINE | ID: mdl-38469819

ABSTRACT

The Expert Panel for Cosmetic Ingredient Safety (Panel) assessed the safety of Hydrogen Peroxide for use in cosmetics. This ingredient is reported to function in cosmetics as an antimicrobial agent, cosmetic biocide, oral health care agent, and oxidizing agent. The Panel reviewed the data relevant to the safety of this ingredient and concluded that Hydrogen Peroxide is safe in cosmetics in the present practices of use and concentration described in this safety assessment.


Subject(s)
Consumer Product Safety , Cosmetics , Hydrogen Peroxide , Hydrogen Peroxide/toxicity , Cosmetics/toxicity , Cosmetics/chemistry , Humans , Animals , Risk Assessment , Toxicity Tests , Oxidants/toxicity
14.
iScience ; 27(4): 109356, 2024 Apr 19.
Article in English | MEDLINE | ID: mdl-38510149

ABSTRACT

Familial Mediterranean fever (FMF) is a periodic fever syndrome caused by variation in MEFV. FMF is known for IL-1ß dysregulation, but the innate immune landscape of this disease has not been comprehensively described. Therefore, we studied circulating inflammatory proteins, and the function of monocytes and (albeit less extensively) neutrophils in treated FMF patients in remission. We found that monocyte IL-1ß and IL-6 production was enhanced upon stimulation, in concordance with alterations in the plasma inflammatory proteome. We did not observe changes in neutrophil functional assays. Subtle differences in chromatin accessibility and transcriptomics in our small patient cohort further argued for monocyte dysregulation. Together, these observations suggest that the MEFV-mutation-mediated primary immune dysregulation in monocytes leads to chronic inflammation that is subsequently associated with counterregulatory epigenetic/transcriptional changes reminiscent of tolerance. These data increase our understanding of the innate immune changes in FMF, aiding future management of chronic inflammation in these patients.

15.
3 Biotech ; 14(3): 82, 2024 Mar.
Article in English | MEDLINE | ID: mdl-38375510

ABSTRACT

Fungal chitosan (FCH) is superior to crustacean chitosan (CH) sources and is of immense interest to the scientific community while having a high demand at the global market. Industrial scale fermentation technologies of FCH production are associated with considerable challenges that frequently restrict their economic production and feasibility. The production of high quality FCH using an underexplored fungal strain Cunninghamella echinulata NCIM 691 that is hoped to mitigate potential future large-scale production was investigated. The one-factor-at-a-time (OFAT) method was implemented to examine the effect of the medium components (i.e. carbon and nitrogen) on the FCH yield. Among these variables, the optimal condition for increased FCH yield was carbon (glucose) and nitrogen (yeast extract) source. A total of 11 factors affected FCH yield among which, the best factors were screened by Plackett-Burman design (PBD). The optimization process was carried out using the response surface methodology (RSM) via Box-Behnken design (BBD). The three-level Box- Behnken factorial design facilitated optimum values for 3 parameters-glucose (2% w/v), yeast extract (1.5% w/v) and magnesium sulphate (0.1% w/v) at 30˚C and pH of 4.5. The optimization resulted in a 2.2-fold higher FCH yield. The produced FCH was confirmed using XRD, 1H NMR, TGA and DSC techniques. The degree of deacetylation (DDA) of the extracted FCH was 88.3%. This optimization process provided a significant improvement of FCH yields and product quality for future potential scale-up processes. This research represents the first report on achieving high FCH yield using a reasonably unfamiliar fungus C. echinulata NCIM 691 through optimised submerged fermentation conditions. Supplementary Information: The online version contains supplementary material available at 10.1007/s13205-024-03919-6.

17.
Adv Sci (Weinh) ; 11(12): e2306729, 2024 Mar.
Article in English | MEDLINE | ID: mdl-38225749

ABSTRACT

Respiratory syncytial virus (RSV) causes substantial morbidity and mortality in infants, the immunocompromised, and the elderly. RSV infects the airway epithelium via the apical membrane and almost exclusively sheds progeny virions back into the airway mucus (AM), making RSV difficult to target by systemically administered therapies. An inhalable "muco-trapping" variant of motavizumab (Mota-MT), a potent neutralizing mAb against RSV F is engineered. Mota-MT traps RSV in AM via polyvalent Fc-mucin bonds, reducing the fraction of fast-moving RSV particles in both fresh pediatric and adult AM by ≈20-30-fold in a Fc-glycan dependent manner, and facilitates clearance from the airways of mice within minutes. Intranasal dosing of Mota-MT eliminated viral load in cotton rats within 2 days. Daily nebulized delivery of Mota-MT to RSV-infected neonatal lambs, beginning 3 days after infection when viral load is at its maximum, led to a 10 000-fold and 100 000-fold reduction in viral load in bronchoalveolar lavage and lung tissues relative to placebo control, respectively. Mota-MT-treated lambs exhibited reduced bronchiolitis, neutrophil infiltration, and airway remodeling than lambs receiving placebo or intramuscular palivizumab. The findings underscore inhaled delivery of muco-trapping mAbs as a promising strategy for the treatment of RSV and other acute respiratory infections.


Subject(s)
Antibodies, Monoclonal , Respiratory Syncytial Virus Infections , Humans , Infant , Child , Animals , Sheep , Mice , Aged , Antibodies, Monoclonal/therapeutic use , Respiratory Syncytial Virus Infections/drug therapy , Palivizumab/therapeutic use , Respiratory Syncytial Viruses , Lung
18.
J Clin Invest ; 134(7)2024 Jan 30.
Article in English | MEDLINE | ID: mdl-38290093

ABSTRACT

The measles, mumps, and rubella (MMR) vaccine protects against all-cause mortality in children, but the immunological mechanisms mediating these effects are poorly known. We systematically investigated whether MMR can induce long-term functional changes in innate immune cells, a process termed trained immunity, that could at least partially mediate this heterologous protection. In a randomized, placebo-controlled trial, 39 healthy adults received either the MMR vaccine or a placebo. Using single-cell RNA-Seq, we found that MMR caused transcriptomic changes in CD14+ monocytes and NK cells, but most profoundly in γδ T cells. Monocyte function was not altered by MMR vaccination. In contrast, the function of γδ T cells was markedly enhanced by MMR vaccination, with higher production of TNF and IFN-γ, as well as upregulation of cellular metabolic pathways. In conclusion, we describe a trained immunity program characterized by modulation of γδ T cell function induced by MMR vaccination.


Subject(s)
Mumps , Rubella , Child , Adult , Humans , Infant , Mumps/prevention & control , Measles-Mumps-Rubella Vaccine , Rubella/prevention & control , Metabolic Reprogramming , Trained Immunity , Vaccination , Antibodies, Viral
19.
Sci Total Environ ; 916: 170064, 2024 Mar 15.
Article in English | MEDLINE | ID: mdl-38242481

ABSTRACT

The unrestricted release of various toxic substances into the environment is a critical global issue, gaining increased attention in modern society. Many of these substances are pristine to various environmental compartments known as contaminants/emerging contaminants (ECs). Nanoparticles and emerging sorbents enhanced remediation is a compelling methodology exhibiting great potential in addressing EC-related issues and facilitating their elimination from the environment, particularly those compounds that demonstrate eco-toxicity and pose considerable challenges in terms of removal. It provides a novel technique enabling the secure and sustainable removal of various ECs, including persistent organic compounds, microplastics, phthalate, etc. This extensive review presents a critical perspective on the current advancements and potential outcomes of nano-enhanced remediation techniques such as photocatalysis, nano-sensing, nano-enhanced sorbents, bio/phyto-remediation, which are applied to clean-up the natural environment. In addition, when dealing with residual contaminants, special attention is paid to both health and environmental implications; therefore, an evaluation of the long-term sustainability of nano-enhanced remediation methods has been considered. The integrated mechanical approaches were thoroughly discussed and presented in graphical forms. Thus, the critical evaluation of the integrated use of most emerging remediation technologies will open a new dimension in environmental safety and clean-up program.


Subject(s)
Environmental Restoration and Remediation , Nanoparticles , Nanostructures , Plastics , Charcoal
20.
Ann Plast Surg ; 92(2): 144-147, 2024 Feb 01.
Article in English | MEDLINE | ID: mdl-38170971

ABSTRACT

BACKGROUND: An increasing number of patients who underwent breast implant surgery are reporting a cluster of concerning physical and psychological symptoms-newly coined term breast implant illness (BII). YouTube is a popular educational tool for plastic surgery patients. OBJECTIVES: The purposes of this study were to assess the quality and reliability of YouTube videos on BII, compare the quality and reliability of different video categories and publishers, and determine the frequencies of reported BII symptoms. METHODS: On YouTube, videos were searched for the term breast implant illness , and the first 100 results were collected. Engagement parameters and symptoms of BII mentioned in each video were recorded. Video power index, a modified DISCERN instrument, and the Global Quality Scale (GQS) were used to assess popularity, reliability, and quality, respectively. RESULTS: Ninety videos met the inclusion criteria. More than half mentioned fatigue (66%), cognitive dysfunction (59%), or muscle and/or joint pain (57%). Videos with a plastic surgeon present had higher DISCERN ( P = 0.001) and GQS ( P = 0.002) scores than those without. Educational videos had higher DISCERN and GQS scores than patient experience ( P < 0.0001, P = 0.001) and entertainment and advertisement videos ( P = 0.014, P = 0.022). Videos published by plastic surgeons had higher Video power index ( P = 0.033), DISCERN ( P < 0.0001), and GQS scores ( P < 0.0001) than those by nonmedical publishers. CONCLUSIONS: The top YouTube videos for BII are generally of low reliability and low-to-moderate quality. Patients unaware of YouTube's limited quality control measures for health education videos are susceptible to misinformation. Additional social media content created by plastic surgeons can improve the quality and accuracy of videos viewed by patients.


Subject(s)
Breast Implantation , Breast Implants , Plastic Surgery Procedures , Social Media , Humans , Reproducibility of Results , Video Recording , Information Dissemination
SELECTION OF CITATIONS
SEARCH DETAIL